CoreValve, Inc.
1 Jenner
Suite 100
Irvine
California
92618
United States
Tel: 949-333-2500
Fax: 949-333-2700
Website: http://www.corevalve.com/
Email: info@corevalve.com
35 articles about CoreValve, Inc.
-
Medtronic Builds on TAVR Clinical Evidence Portfolio with Five-Year CoreValve Durability Data and Complete Two-Year Outcomes in Intermediate Risk Aortic Stenosis Patients
9/24/2018
TCT18: New Five-Year Data with CoreValve TAVR System Suggests Durability Over Time, While Complete Results from the SURTAVI Trial Show Benefits of TAVR in Intermediate Risk Patients
-
Sofinnova Partners Announces the Sale of ReCor Medical to Otsuka Holdings
7/10/2018
Sofinnova Partners today announced that Otsuka Holdings is acquiring its portfolio company ReCor Medical.
-
Medtronic, Inc. Completes Acquisition of CoreValve, Inc.
4/10/2009
-
CoreValve, Inc. to be Acquired by Medtronic, Inc. for $700+ Million
2/23/2009
-
CoreValve, Inc. Prevails in United Kingdom Patent Infringement Action
1/9/2009
-
German Court Finds Edwards Lifesciences' Transcatheter Valve Patent Not Infringed by CoreValve, Inc.
10/16/2008
-
CoreValve, Inc. Wins Patent Infringement Action in Germany
10/16/2008
-
CoreValve, Inc. Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValvingĀ® System for Percutaneous Aortic Valve Replacement (PAVR)
10/13/2008
-
CoreValve, Inc. Elects Industry Veteran Frank Fischer to its Board of Directors
10/9/2008
-
CoreValve, Inc. Announces Successful Completion of Initial Series of Proctored Cases in Australia and New Zealand Using Its ReValving(R) System for Percutaneous Aortic Valve Replacement
9/8/2008
-
CoreValve, Inc. Successfully Treats the First Pacific Rim Patients with Its ReValving(R) System for Percutaneous Aortic Valve Replacement
8/28/2008
-
CoreValve, Inc. Announces that more than 1,000 High-risk Patients have been Treated with its ReValving(R) System for Percutaneous Aortic Valve Replacement (PAVR)
5/15/2008
-
CoreValve, Inc. Names Vito A. Canuso III as Vice President, Intellectual Property
5/2/2008
-
CoreValve, Inc. Names New CEO
4/30/2008
-
CoreValve, S.A. Refutes Alleged Patent Infringement Action by Edwards Lifesciences
2/15/2008
-
Edwards Lifesciences Corporation Initiates Patent Infringement Litigation Against CoreValve, S.A. in the U.S.
2/13/2008
-
CoreValve, S.A. Announces that more than 500 High-risk Patients have been Treated with its ReValving(R) System for Percutaneous Aortic Valve Replacement (PAVR)
1/7/2008
-
CoreValve, S.A. to present at JPMorgan 2008 Healthcare Conference
1/3/2008
-
CoreValve, S.A. Named a ''Red Herring 100 Global Award'' Winner as ''One of the Top-100 Tech Start-Ups in the World''
12/10/2007
-
CoreValve, S.A. Named To Red Herring Magazine's "Top 100" North American Private Companies
7/24/2007